Global Top 4 Companies Accounted for 72% of total Fc Fusion Protein market (Business Opportunities - Investment)
CANetAds > Business Opportunities > Investment
Item ID 3873141 in Category: Business Opportunities - Investment
Global Top 4 Companies Accounted for 72% of total Fc Fusion Protein market | |
Fc fusion protein is composed of the Fc segment of immunoglobulin and protein molecules with biological activity. The Fc segment and the functional protein have relatively independent structural domains and functions, which can affect the physical and chemical properties and biological activities of the fusion protein from different angles. Fc-fusion proteins are bioengineered polypeptides that join the crystallizable fragment (Fc) domain of an antibody with another biologically active protein domain or peptide to generate a molecule with unique structure–function properties and significant therapeutic potential. The gamma immunoglobulin (IgG) isotype is often used as the basis for generating Fc-fusion proteins This report will focus on Fc fusion protein drugs. The global key manufacturers of Fc Fusion Protein include Amgen, Eli Lilly and Company, Regeneron, Bristol-Myers Squibb, Bayer, etc. In 2021, the global top four players had a share approximately 72.0% in terms of revenue. For more information, please contact the following e-mail address: Email: global@qyresearch.com Website: https://www.qyresearch.com  | |
| Target Prov.: All Provinces Target City : All Cities Last Update : May 15, 2024 1:48 AM Number of Views: 69 | Item Owner : Diana Contact Email: (None) Contact Phone: (None) |
| Friendly reminder: Click here to read some tips. | |
CANetAds > Business Opportunities > Investment
© 2024 CANetAds.com
USNetAds.com | GetJob.us | UKAdsList.com | AUNetAds.com | INNetAds.com | CNNetAds.com | Hot-Web-Ads.com | USAOnlineClassifieds.com
2024-11-22 (0.438 sec)